Ha Ngoc Tuan

Avg. Two Year Performance

(60%) Avg. Purchase Return
(26%) Compound
83% Avg. Sale Return
35% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return20%10%(40%)(47%)(60%)
Purchase Success Rate1 of 43 of 41 of 41 of 41 of 4
Average Sale Return(8%)8%6%33%83%
Sale Success Rate1 of 43 of 43 of 44 of 44 of 4

ArQule Inc.

Drugs » Drug Manufacturers - Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Human Genome Sciences Inc.

Drugs » Diagnostic Substances

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

AVEO Pharmaceuticals, Inc.

Drugs » Biotechnology

Director:

Holdings: 381.57K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--